Zobrazeno 1 - 9
of 9
pro vyhledávání: '"George Vasmatzis, PhD"'
Autor:
Kaushal Parikh, MD, Faye R. Harris, MS, Giannoula Karagouga, MS, Amy Schrandt, CRA, Jay Mandrekar, PhD, Sarah Johnson, MS, Alexa McCune, BS, Dorsay Sadeghian, MD, Debarshi Roy, PhD, Katarzyna Polonis, PhD, Athanasios Gaitatzes, MS, Aaron O. Bungum, BS, Eric S. Edell, MD, Mitesh J. Borad, MD, Tobias Peikert, MD, Farhad Kosari, PhD, John Cheville, MD, George Vasmatzis, PhD, Aaron S. Mansfield, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 12, Pp 100692- (2024)
Introduction: The spatially complex nature of mesothelioma and interventions like pleurodesis, surgery, and radiation often complicate imaging-based assessment. Further, cell-free DNA (cfDNA) based monitoring strategies are inadequate for mesotheliom
Externí odkaz:
https://doaj.org/article/aa57a27ee45d48ffae93e50fd75eed69
Autor:
Ying-Chun Lo, MD, PhD, Joel Rivera-Concepcion, MD, George Vasmatzis, PhD, Marie-Christine Aubry, MD, Konstantinos Leventakos, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 9, Pp 100561- (2023)
Introduction: SCLC is an aggressive malignancy with poor outcome. Most patients have disease recurrence despite treatments with multiple modalities. Subtyping of SCLC has been proposed recently, and novel agents targeting specific subtypes are active
Externí odkaz:
https://doaj.org/article/3d147a6b289f4e73b961f1a09509fc15
Autor:
Paxton, Anne
Publikováno v:
CAP Today. Nov2019, Vol. 33 Issue 11, p1-20. 5p.
Publikováno v:
Journal of Thoracic Oncology; Sep2019, Vol. 14 Issue 9, pA15-A20, 6p
Publikováno v:
Journal of Thoracic Oncology; Jul2019, Vol. 14 Issue 7, pA13-A18, 6p
Publikováno v:
Otology & Neurotology; Apr2018, Vol. 39 Issue 4, p521-525, 5p
Publikováno v:
Otology & Neurotology; Mar2018, Vol. 39 Issue 3, p390-394, 5p
Autor:
Harbor, National
Publikováno v:
Otology & Neurotology; Feb2018, Vol. 39 Issue 2, p260-264, 5p
Autor:
PERRON, MICHELLE
Publikováno v:
Oncology Times; 2/10/2017, Vol. 39 Issue 3, p14-15, 2p